The BioEscalator publishes its Portfolio 2025 – a guide for potential partners & investors

The BioEscalator, the University of Oxford’s biomedical incubator, is home to a stellar collection of companies using cutting-edge science to tackle profound medical challenges.

The new Portfolio 2025 brings them together to showcase their innovative approaches and provide a valuable guide for potential investors and partners.

The Portfolio 2025 includes:

A foreword from Tim Funnell, Partner at Monograph Capital
One-page profiles of tenants, from founders and funding to achievements and ambitions
A map of their partners and investors across the world
The alumni
BioEscalator achievement metrics

The Portfolio 2025 is a guide to the activities of BioEscalator tenants – you can make contact with them via the details given in their profiles, or via the BioEscalator team, if you would like to know more.

BioEscalator_partner_brands_Quadrangle_ForWhiteBackgrounds

← Previous

Recent news

Sauber Motorsport opens Technology Centre at Bicester Motion

Jul 3, 2025

Sauber Motorsport has opened its new Technology Centre at Bicester Motion. The primary purpose of the facility at the 444-acre future mobility estate is to enhance and expand the team’s technical capabilities, to ensure the team is well-positioned to attract top...

Immunocore Wins Prix Galien UK Award for KIMMTRAK

Jul 2, 2025

Immunocore has been awarded a Prix Galien UK award for KIMMTRAK, its treatment for metastatic uveal melanoma- a rare and aggressive form of eye cancer. The Prix Galien UK is one of the highest accolades in the life sciences sector, recognising outstanding innovation...

Business and Trade Committee Launches Two Important Inquiries

Jun 17, 2025

The UK’s Business and Trade Committee has recently announced the launch of two significant inquiries- both of which present crucial opportunities for stakeholders across business, research, and innovation sectors to have their voices heard at a national level. UK...